In addition to erythroderma, SS is characterized by circulating malignant T cells that mirror the skin infiltrate, as well as evidence of an increased blood tumor burden (B2 stage) with aberrant T‐cell phenotypes, such as CD4+/CD26− or CD4+/CD7− populations, identified by flow cytometry.3 This evidence concerns the gene CD4 and synovial sarcoma.